“…In another cohort of 42 patients with talaromycosis, 22 were positive for anti-IFNγ auto-antibodies [ 122 ]. In patients with positive anti-IFNγ auto-antibodies, disseminated disease was more common, as well as coinfections with other pathogens (such as NTM) and they demonstrated a higher mortality [ 24 , 39 , 122 , 123 , 124 , 125 ]. In two systemic reviews of patients with anti-IFNγ auto-antibodies, 18.3%, respectively, 16.3% of these patients with anti-IFNγ auto-antibodies were diagnosed with talaromycosis [ 20 , 23 ], the second most common infection after NTM infections.…”